ECOG-ACRIN E1411

Primary Category:

Treatment Protocols

Disease Category:

Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma

Status:

Closed

Intergroup Randomized Phase II Four Arm Study In Patients With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB → R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV→ R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB → LR) or Arm D = Rituximab Bendamustine + Bortezomib Followed By Lenalidomide + Rituximab Consolidation (RBV → LR)

 

E1411 is successfully approaching its accrual goal, therefore this study will be closed to accrual effective September 9, 2016 at 5:00pm ET.

NCT#01415752

Leave a Reply